#United States #Irvine #Orthopedics #SmartTRAK #Neuro Therapies

Innovating MedTech Intelligence

In the fast-evolving world of medical technology, the demand for actionable data is greater than ever. SmartTRAK, a trailblazer in MedTech market intelligence, has recently introduced ground-breaking analytics tools that aim to redefine how companies within the orthopedics and neuro therapies sectors operate. This new suite of resources is particularly focused on the hip and knee markets, promising to yield insights that are not only faster but also more precise than traditional methods.

Enhanced Decision-Making: A Game Changer

One of the primary objectives of SmartTRAK's latest offerings is to streamline strategic decision-making processes. By simplifying access to data, these tools alleviate the burden of complex and expensive datasets that have historically posed challenges for many companies. This is particularly vital for organizations looking to quickly adapt to market changes and consumer needs.

The new tools include dynamic charts, comprehensive growth analyses, and detailed breakdowns of market share by various parameters. Regular updates ensure that the data remains relevant, covering up to five years of trends in the product mix, average pricing, and market share segmented by types of facilities.

Global Insight with the OUS Procedure Tracker

The introduction of the OUS (Outside the United States) Procedure Tracker represents a significant advancement for companies operating internationally. This tool, powered by Quomeda, features extensive analysis of hip and knee procedure volumes across Europe, Latin America, and Asia-Pacific, providing valuable insights from as far back as 2018, with projections extending to 2026. Upcoming expansions into areas such as foot and ankle, spine, and knee soft tissue fixation underscore SmartTRAK’s commitment to delivering precise geographic insights tailored to the needs of its clients.

Speed and Efficiency: The US Procedure Tracker

Scheduled for launch in spring 2025, the US Procedure Tracker will revolutionize how companies access procedure insights. Covering 87% of commercial claims as well as 90% of Medicare Fee-for-Service and Medicaid claims nationwide, the tool allows for real-time data retrieval. It empowers users to identify trends by demographics, region, segment, and site of care, thus enabling rapid response strategies. Plans for future updates include extending coverage to other orthopedic markets like the shoulder, foot and ankle, and spine, further enhancing its utility.

Expert Analysts at Your Service

To ensure that clients extract maximum value from these tools, SmartTRAK emphasizes a human touch to its data offerings. Elise Wolf, the VP/GM of Orthopedics at SmartTRAK, notes that their tools combine cutting-edge technology with expert analysis. This ensures that clients have direct access to insights and advice from industry professionals, empowering their decisions in an often volatile market.

SmartTRAK is also enhancing its ASC (Ambulatory Surgery Center) Insights solution, which will now include in-depth analytics related to both procedures and real estate, further catering to the growing ASC market.

Looking Forward

As 2025 unfolds, SmartTRAK is poised to lead the MedTech industry into a new era characterized by swift, data-driven decision-making. The company plans to showcase these innovative solutions at the upcoming AAOS (American Academy of Orthopaedic Surgeons) Annual Meeting in San Diego, where it will be a featured sponsor of the OrthoPitch competition. Attendees can explore these pioneering tools at Booth #2710 from March 11-13.

In conclusion, with SmartTRAK’s latest advancements, orthopedics, and neuro therapies organizations are now better equipped to navigate complex market dynamics and make informed strategic choices. The future indeed looks bright for SmartTRAK and its clients as they step into a more organized, information-rich environment.